Robert DuBose

5.2k total citations · 4 hit papers
26 papers, 4.2k citations indexed

About

Robert DuBose is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Robert DuBose has authored 26 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 10 papers in Immunology and 4 papers in Oncology. Recurrent topics in Robert DuBose's work include Immune Cell Function and Interaction (4 papers), Bacterial Genetics and Biotechnology (4 papers) and Immunotherapy and Immune Responses (4 papers). Robert DuBose is often cited by papers focused on Immune Cell Function and Interaction (4 papers), Bacterial Genetics and Biotechnology (4 papers) and Immunotherapy and Immune Responses (4 papers). Robert DuBose collaborates with scholars based in United States, Canada and Zimbabwe. Robert DuBose's co-authors include David Cosman, Dirk Anderson, Eugene Maraskovsky, Laurent Galibert, Mark Tometsko, Mark Teepe, Eileen R. Roux, William C. Dougall, Brian W. Matthews and Raymond H. Jacobson and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and The Journal of Experimental Medicine.

In The Last Decade

Robert DuBose

25 papers receiving 4.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function

1997 1.8k citations Dirk Anderson, Eugene Maraskovsky et al. Nature profile →
Cloning and Characterization of TRAIL-R3, a Novel Member of the Emerging TRAIL Receptor Family

1997 543 citations Mariapia A. Degli‐Esposti, Pamela J. Smolak et al. The Journal of Experimental Medicine profile →
Identification and cloning of a novel IL-15 binding protein that is structurally related to the alpha chain of the IL-2 receptor.

1995 542 citations Judith G. Giri, Satoru Kumaki et al. profile →
Three-dimensional structure of β-galactosidase from E. coli.

1994 508 citations Raymond H. Jacobson, Robert DuBose et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robert DuBose United States	15	2.7k	1.5k	1.3k	743	362	26	4.2k
Fumiyo Ikeda Japan	32	4.3k 1.6×	1.5k 1.1×	1.5k 1.2×	1.4k 1.9×	318 0.9×	52	5.5k
Kensuke Miyake Japan	38	2.4k 0.9×	687 0.5×	2.8k 2.2×	474 0.6×	217 0.6×	92	6.3k
Santos Mañes Spain	46	3.2k 1.2×	1.7k 1.2×	2.5k 1.9×	881 1.2×	291 0.8×	88	6.9k
Jie Yang China	34	2.0k 0.7×	1.3k 0.9×	1.1k 0.8×	602 0.8×	144 0.4×	126	3.7k
Malcolm Lyon United Kingdom	42	3.0k 1.1×	245 0.2×	889 0.7×	378 0.5×	456 1.3×	69	5.2k
David L. Urdal United States	38	2.7k 1.0×	1.5k 1.0×	4.8k 3.7×	441 0.6×	638 1.8×	57	7.9k
Martyn K. Robinson United Kingdom	26	1.0k 0.4×	407 0.3×	795 0.6×	149 0.2×	390 1.1×	46	2.6k
Mouldy Sioud Norway	42	4.5k 1.6×	856 0.6×	2.4k 1.9×	949 1.3×	641 1.8×	205	6.9k
Nicholas Harris United States	23	1.5k 0.5×	663 0.5×	1.4k 1.1×	189 0.3×	246 0.7×	37	3.5k
Kenzaburo Tani Japan	38	2.4k 0.9×	1.2k 0.8×	1.4k 1.1×	285 0.4×	1.1k 3.0×	225	5.4k

Countries citing papers authored by Robert DuBose

Since Specialization

Citations

This map shows the geographic impact of Robert DuBose's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert DuBose with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert DuBose more than expected).

Fields of papers citing papers by Robert DuBose

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert DuBose. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert DuBose. The network helps show where Robert DuBose may publish in the future.

Co-authorship network of co-authors of Robert DuBose

This figure shows the co-authorship network connecting the top 25 collaborators of Robert DuBose. A scholar is included among the top collaborators of Robert DuBose based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert DuBose. Robert DuBose is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jové, Veronica, Robert DuBose, Sandeep Saha, et al.. (2024). 39 (PB027): TEAD inhibition by SW-682 potentiates activity of targeted therapies in NSCLC models. European Journal of Cancer. 211. 114567–114567. 1 indexed citations

Chen, Lei, Luigi Celentano, Veronica Jové, et al.. (2024). 234 (PB222): Rational combination of pan-TEAD inhibitor SW-682 and MEK inhibitor mirdametinib in head and neck squamous cell carcinomas leads to synergistic response. European Journal of Cancer. 211. 114752–114752. 1 indexed citations

Metz, Heather, Ty Brender, Michael R. Comeau, et al.. (2020). 712 SBT6290, a systemically administered Nectin-4-directed TLR8 ImmunoTAC (TM) therapeutic, is a potent human myeloid cell agonist for the treatment of Nectin-4-expressing tumors. SHILAP Revista de lepidopterología. A427.1–A427. 2 indexed citations

Odegard, Valerie, Kara White Moyes, Ty Brender, et al.. (2020). Abstract PD4-09: Preclinical studies support the development of SBT6050, an anti-HER2 antibody conjugated to a potent TLR8 agonist, for treatment of moderate and high HER2-expressing tumors that lack pre-existing T cell infiltrate. Cancer Research. 80(4_Supplement). PD4–9. 1 indexed citations

Umakanthan, Ramanan, Robert DuBose, John G. Byrne, & Rashid Ahmad. (2010). Preoperative Optimization of Multi-Organ Failure Following Acute Myocardial Infarction and Ischemic Mitral Regurgitation by Placement of a Transthoracic Intra-Aortic Balloon Pump. The Heart Surgery Forum. 13(5). E342–E344. 1 indexed citations

Cosman, David, Satoru Kumaki, Minoo Ahdieh, et al.. (2007). Interleukin 15 and Its Receptor. Novartis Foundation symposium. 195. 221–233. 5 indexed citations

Patterson, Scott D. & Robert DuBose. (2006). The role of biomarkers in the future of drug development. Expert Opinion on Drug Discovery. 1(3). 199–204. 1 indexed citations

Severino, Michael E., Robert DuBose, & Scott D. Patterson. (2006). A strategic view on the use of pharmacodynamic biomarkers in early clinical drug development.. PubMed. 9(12). 849–53. 6 indexed citations

Nelson, Nicole, et al.. (1999). The identification of seven metalloproteinase-disintegrin (ADAM) genes from genomic libraries. Gene. 237(1). 61–70. 31 indexed citations

10.

Cerretti, Douglas Pat, Robert DuBose, Roy A. Black, & Nicole Nelson. (1999). Isolation of Two Novel Metalloproteinase-Disintegrin (ADAM) cDNAs That Show Testis-Specific Gene Expression. Biochemical and Biophysical Research Communications. 263(3). 810–815. 45 indexed citations

11.

Comeau, Michael R., Richard D. Johnson, Robert DuBose, et al.. (1998). A Poxvirus-Encoded Semaphorin Induces Cytokine Production from Monocytes and Binds to a Novel Cellular Semaphorin Receptor, VESPR. Immunity. 8(4). 473–482. 206 indexed citations

12.

Strockbine, L, Jeffrey I. Cohen, Terry Farrah, et al.. (1998). The Epstein-Barr Virus BARF1 Gene Encodes a Novel, Soluble Colony-Stimulating Factor-1 Receptor. Journal of Virology. 72(5). 4015–4021. 117 indexed citations

13.

Degli‐Esposti, Mariapia A., Pamela J. Smolak, Henning Walczak, et al.. (1997). Cloning and Characterization of TRAIL-R3, a Novel Member of the Emerging TRAIL Receptor Family. The Journal of Experimental Medicine. 186(7). 1165–1170. 543 indexed citations breakdown →

14.

Anderson, Dirk, Eugene Maraskovsky, William C. Dougall, et al.. (1997). A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature. 390(6656). 175–179. 1824 indexed citations breakdown →

15.

Sudarsanam, Sucha, et al.. (1995). Modeling protein loops using a ϕ_i+1, Ψ_i dimer database. Protein Science. 4(7). 1412–1420. 39 indexed citations

16.

Jacobson, Raymond H., et al.. (1994). Three-dimensional structure of β-galactosidase from E. coli.. Nature. 369(6483). 761–766. 508 indexed citations breakdown →

17.

DuBose, Robert & Daniel L. Hartl. (1990). The molecular evolution of bacterial alkaline phosphatase: correlating variation among enteric bacteria to experimental manipulations of the protein.. Molecular Biology and Evolution. 7(6). 547–77. 12 indexed citations

18.

Hall, B G, et al.. (1989). IS103, a new insertion element in Escherichia coli: characterization and distribution in natural populations.. Genetics. 121(3). 423–431. 23 indexed citations

19.

Lawrence, Jeffrey G., D E Dykhuizen, Robert DuBose, & Daniel L. Hartl. (1989). Phylogenetic analysis using insertion sequence fingerprinting in Escherichia coli.. Molecular Biology and Evolution. 6(1). 1–14. 28 indexed citations

20.

DuBose, Robert, D E Dykhuizen, & Daniel L. Hartl. (1988). Genetic exchange among natural isolates of bacteria: recombination within the phoA gene of Escherichia coli.. Proceedings of the National Academy of Sciences. 85(18). 7036–7040. 100 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact